February 18, 2020
Steve Dayan, MD
With a novel topical agent (tapinarof) in development for psoriasis, Dermavant is rooted in dermatology with an eye toward aesthetics. Dermavant CEO and industry veteran Todd Zavodnick talks to host Steven Dayan, MD about the company, its culture, and its future.
Steve Dayan, MD; and Alexandra Wilkis Wilson